Our previous studies showed that CREB is highly upregulated and hyperphosphorylated in most of the non-small cell lung cancer (NSCLC) tumor specimens and that this upregulation is significantly associated with poor survival rates [10–12]. This evidence concerns the gene CREB1 and non-small cell lung carcinoma.